InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Fulcrum Therapeutics, Inc.

FULC Clue Score33
United States Fiscal year ends December CIK 0001680581 Results filed 27 Apr 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

98
Insider
Date
Role
Action
Shares
Price
Amount
Kevin Tang
17 Jul 2026
10% owner
Buy indirect
50,945
$3.52
$179.33K
Kevin Tang
16 Jul 2026
10% owner
Buy indirect
116,671
$3.56
$415.35K
Kevin Tang
15 Jul 2026
10% owner
Buy indirect
107,377
$3.56
$382.26K
Kevin Tang
14 Jul 2026
10% owner
Buy indirect
75,952
$3.58
$271.91K
Kevin Tang
14 Jul 2026
10% owner
Buy indirect
53,651
$3.56
$191.00K
Kevin Tang
13 Jul 2026
10% owner
Buy indirect
12,966
$3.54
$45.90K
Alan Ezekowitz
26 Jun 2026
Director
Sell
18,000
$3.65
$65.61K
Robert J Gould
2 Feb 2026
Director
Sell
15,000
$10.72
$160.86K
Robert J Gould
2 Jan 2026
Director
Sell
15,000
$11.87
$178.09K
Curtis Gale Oltmans
15 Dec 2025
Chief Legal Officer
Sell
3,452
$12.92
$44.60K
Ra Capital Management, L.p.
8 Dec 2025
10% owner
Sell indirect
91,722
$14.98
$1.37M
Ra Capital Management, L.p.
8 Dec 2025
10% owner
Sell indirect
2,706,397
$14.28
$38.65M
Ra Capital Management, L.p.
8 Dec 2025
10% owner
Sell indirect
1,377,020
$13.33
$18.36M
Robert J Gould
19 Nov 2025
Director
Sell
15,000
$11.03
$165.50K
Greg Tourangeau
8 May 2025
Principal Accounting Officer
Sell
498
$5.06
$2.52K
Alex Sapir
3 Jul 2024
See Remarks
Exercised, kept
150,000
$3.27
$490.50K
Greg Tourangeau
7 May 2024
Principal Accounting Officer
Sell
236
$7.76
$1.83K
Greg Tourangeau
8 Mar 2024
Vice President, Finance
Sell
4,884
$11.72
$57.22K
Alex Sapir
4 Mar 2024
See Remarks
Buy
43,360
$11.35
$492.03K
Greg Tourangeau
10 May 2023
Principal Accounting Officer
Sell
210
$3.31
$695.10
Ra Capital Management, L.p.
20 Jan 2023
10% owner
Buy indirect
1,923,076
$13.00
$25.00M
Robert J Gould
13 Jan 2023
Interim President & CEO
Sell
6,766
$15.00
$101.49K
Ra Capital Management, L.p.
4 Jan 2023
10% owner
Buy indirect
58,369
$7.80
$455.09K
Ra Capital Management, L.p.
4 Jan 2023
10% owner
Buy indirect
122,334
$7.03
$859.71K
Ra Capital Management, L.p.
27 Dec 2022
10% owner
Buy indirect
4,089
$5.99
$24.51K
Ra Capital Management, L.p.
19 Dec 2022
10% owner
Buy indirect
98,787
$5.90
$582.81K
Ra Capital Management, L.p.
16 Dec 2022
10% owner
Buy indirect
1,341,420
$5.42
$7.27M
Ra Capital Management, L.p.
15 Dec 2022
10% owner
Buy indirect
237,029
$5.50
$1.30M
Ra Capital Management, L.p.
14 Dec 2022
10% owner
Buy indirect
824,600
$5.46
$4.50M
Robert J Gould
7 Jun 2022
Director
Sold after exercise
71,435
$8.09
$577.89K
Robert J Gould
6 Jun 2022
Director
Sold after exercise
24,382
$8.10
$197.59K
Robert J Gould
3 Jun 2022
Director
Sold after exercise
25,551
$7.95
$203.06K
Robert J Gould
2 Jun 2022
Director
Sold after exercise
16,689
$7.92
$132.16K
Robert J Gould
7 Apr 2022
Director
Sold after exercise
5,631
$24.02
$135.23K
Robert J Gould
5 Apr 2022
Director
Sold after exercise
52,552
$24.26
$1.27M
Robert J Gould
4 Apr 2022
Director
Sold after exercise
7,235
$24.02
$173.75K
Robert J Gould
1 Apr 2022
Director
Sold after exercise
34,464
$24.03
$828.16K
Bryan Stuart
11 Aug 2021
See Remarks
Sold after exercise
28,000
$23.75
$665.00K
Bryan Stuart
10 Aug 2021
See Remarks
Sold after exercise
32,000
$17.50
$560.00K
Christopher Moxham
10 Aug 2021
Chief Scientific Officer
Sold after exercise
31,071
$18.00
$559.28K
Christopher Moxham
10 Aug 2021
Chief Scientific Officer
Sold after exercise
20,714
$17.00
$352.14K
James A Geraghty
28 Jun 2021
Director
Buy
10,000
$9.16
$91.60K
Peter G. Thomson
28 Jun 2021
VP Finance & Accounting
Buy indirect
2,300
$9.00
$20.70K
Curtis Gale Oltmans
28 Jun 2021
SVP, General Counsel
Buy
1,088
$9.01
$9.80K
Christopher Morabito
28 Jun 2021
Chief Medical Officer
Buy
1,100
$9.16
$10.08K
Robert J Gould
16 Mar 2021
See Remarks
Sell
789
$12.43
$9.81K
Robert J Gould
15 Mar 2021
See Remarks
Sell
9,211
$12.13
$111.77K
Peter G. Thomson
22 Feb 2021
VP Finance & Accounting
Sold after exercise
5,000
$14.72
$73.58K
Robert J Gould
16 Feb 2021
See Remarks
Sell
1,673
$14.56
$24.37K
Robert J Gould
16 Feb 2021
See Remarks
Sell
6,542
$14.19
$92.83K
Peter G. Thomson
21 Jan 2021
VP Finance & Accounting
Sell
6,607
$14.00
$92.50K
Robert J Gould
20 Jan 2021
See Remarks
Sell
10,000
$12.08
$120.83K
Owen B. Wallace
14 Sep 2020
Chief Scientific Officer
Exercised, kept
6,350
$7.84
$49.78K
Robert J Gould
8 Jul 2020
See Remarks
Sell
2,500
$20.00
$50.00K
Owen B. Wallace
8 Jul 2020
Chief Scientific Officer
Sold after exercise
2,951
$20.00
$59.02K
Diego Cadavid
1 Jul 2020
SVP Clinical Development
Sell
1,071
$18.30
$19.60K
Owen B. Wallace
30 Jun 2020
Chief Scientific Officer
Sold after exercise
141
$20.00
$2.82K
Robert J Gould
25 Jun 2020
See Remarks
Sell
2,500
$20.80
$51.99K
Diego Cadavid
25 Jun 2020
SVP Clinical Development
Sold after exercise
1,459
$22.00
$32.10K
Diego Cadavid
10 Jun 2020
SVP Clinical Development
Sold after exercise
401
$22.00
$8.82K
Robert J Gould
9 Jun 2020
See Remarks
Sell
156
$20.00
$3.12K
Diego Cadavid
5 Jun 2020
SVP Clinical Development
Sold after exercise
451
$20.18
$9.10K
Robert J Gould
5 Jun 2020
See Remarks
Sell
3,433
$20.17
$69.25K
Robert J Gould
4 Jun 2020
See Remarks
Sell
1,300
$20.04
$26.06K
Diego Cadavid
4 Jun 2020
SVP Clinical Development
Sold after exercise
226
$20.05
$4.53K
Diego Cadavid
3 Jun 2020
SVP Clinical Development
Sold after exercise
338
$20.18
$6.82K
Robert J Gould
3 Jun 2020
See Remarks
Sell
1,500
$20.13
$30.19K
Robert J Gould
2 Jun 2020
See Remarks
Sell
2,797
$20.00
$55.94K
Diego Cadavid
2 Jun 2020
SVP Clinical Development
Sold after exercise
45
$20.00
$900.00
Robert J Gould
1 Jun 2020
See Remarks
Sell
5
$20.00
$100.00
Robert J Gould
29 May 2020
See Remarks
Sell
1,390
$20.08
$27.91K
Diego Cadavid
29 May 2020
SVP Clinical Development
Sold after exercise
200
$20.04
$4.01K
Owen B. Wallace
28 May 2020
Chief Scientific Officer
Sold after exercise
2,232
$20.00
$44.64K
Robert J Gould
28 May 2020
See Remarks
Sell
1,919
$20.01
$38.39K
Diego Cadavid
28 May 2020
SVP Clinical Development
Sold after exercise
600
$20.00
$12.00K
Owen B. Wallace
27 May 2020
Chief Scientific Officer
Sold after exercise
448
$20.00
$8.96K
Robert J Gould
26 May 2020
See Remarks
Sell
2,500
$20.00
$50.00K
Owen B. Wallace
26 May 2020
Chief Scientific Officer
Sold after exercise
412
$20.00
$8.24K
Diego Cadavid
12 May 2020
SVP Clinical Development
Sold after exercise
1,860
$18.00
$33.48K
Peter G. Thomson
11 May 2020
VP Finance & Accounting
Sell
7,500
$16.00
$120.00K
Diego Cadavid
2 Mar 2020
SVP Clinical Development
Sell
315
$18.13
$5.71K
Diego Cadavid
2 Mar 2020
SVP Clinical Development
Sell
1,828
$17.26
$31.55K
Peter G. Thomson
24 Feb 2020
VP Finance & Accounting
Sell
250
$18.61
$4.65K
Peter G. Thomson
24 Feb 2020
VP Finance & Accounting
Sell
2,102
$17.43
$36.64K
Peter G. Thomson
24 Feb 2020
VP Finance & Accounting
Sell
2,648
$16.18
$42.86K
Owen B. Wallace
19 Feb 2020
Chief Scientific Officer
Sold after exercise
6,088
$20.00
$121.76K
Robert J Gould
19 Feb 2020
See Remarks
Sell
2,500
$20.00
$50.00K
Diego Cadavid
3 Feb 2020
SVP Clinical Development
Sell
2,143
$17.33
$37.14K
Peter G. Thomson
23 Jan 2020
VP Finance & Accounting
Sell
262
$18.05
$4.73K
Peter G. Thomson
23 Jan 2020
VP Finance & Accounting
Sell
4,738
$17.17
$81.37K
Mark J Levin
22 Jul 2019
Director
Buy indirect
81,250
$16.00
$1.30M
Casdin Capital, LLC
22 Jul 2019
10% owner
Buy indirect
5,000
$14.50
$72.50K
Casdin Capital, LLC
22 Jul 2019
10% owner
Buy indirect
10,000
$14.50
$145.00K
Casdin Capital, LLC
22 Jul 2019
10% owner
Buy indirect
125,000
$16.00
$2.00M
6 Dimensions Capital, L.P.
22 Jul 2019
10% owner
Buy
118,750
$16.00
$1.90M
Third Rock Ventures III, L.P.
22 Jul 2019
10% owner
Buy
81,250
$16.00
$1.30M
Third Rock Ventures IV, L.P.
22 Jul 2019
10% owner
Buy
81,250
$16.00
$1.30M
Sanofi
22 Jul 2019
10% owner
Buy indirect
93,750
$16.00
$1.50M

What was left out

Form 4 filings counted 183
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 28
Sales at will 41
Transactions with no price 0
Shares from compensation/vesting 32,104,196
Sales filed before the plan box existed 29
History held since 18 Jul 2019